Methods for setting up, maintaining and operating a radiopharmaceutical infusion system, that includes a radioisotope generator, are facilitated by a computer of the system. The computer may include pre-programmed instructions and a computer interface, for interaction with a user of the system, for example, in order to track contained volumes of eluant and/or eluate, and/or to track time from completion of an elution performed by the system, and/or to calculate one or more system and/or injection parameters for quality control, and/or to perform purges of the system, and/or to facilitate diagnostic imaging.

An infusion pump is configured to execute one or more alarm actions according to an alarm protocol. An alarm manager of the infusion pump is configured to receive alarm configuration comprising one or more alarm protocols, each protocol comprising one or more alarm parameters. The alarm manager is also configured to determine the presence of an alarm condition and perform an action associated with the one or more alarm parameters in response to determining the presence of the error condition.

A ventilation management system stores an initial configuration profile including a set of operating parameters for operating one or more respective ventilation devices. The system receives first ventilator data from a first ventilation device at a first location, and second ventilator data from a second ventilation device at a second location, the first and second ventilation devices being configured to operate based on the initial configuration profile, wherein the received first ventilator data comprises one or more current operating parameters of the first ventilation device, or physiological data obtained from a patient associated with the first ventilation device. The system modifies the initial configuration profile for use by the first ventilation device based on the received first ventilation data and provides the modified configuration profile to the first ventilation device. The modified configuration profile is implemented by the first ventilation device when approved by a clinician or the patient.

Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.

Provided is a system including a plurality of inhalers that each include a processor configured to determine a value of a usage parameter relating to use of the respective first inhaler, encrypt data based on the value, and transmit the encrypted data. At least two of the inhalers include different medicament, such as a rescue medicament and a maintenance medicament. The system includes an external device that includes a processor configured to distinguish between the encrypted data of each respective inhaler, determine respective usage information relating to each of the distinct types of medicament based on the respective encrypted data, and control a user interface (e.g., of the external device) to communicate the usage information related to each inhaler and/or each respective type of medicament.

An apparatus that includes at least one nebulizer that includes a mesh material having a plurality of pores, a vibrating actuator coupled to the nebulizer and configured to produce ultrasonic vibration when energized according to a set energy profile, and a reservoir receiver configured to receive a reservoir that holds a topical formulation, the reservoir being coupled to the nebulizer when received. When the nebulizer is placed in contact with the topical formulation, vibration of the mesh nebulizer by the vibrating actuator, according to the set energy profile, ejects droplets of the topical formulation from the plurality of pores, forming a spray.

Modules for housing electronic and electromechanical medical equipment including a system to measure and record administration of one or more IV medications or fluids for IV administration.

Modules for housing electronic and electromechanical medical equipment including a system to measure and record administration of one or more IV medications or fluids for IV administration.

Embodiments of negative pressure wound therapy devices and methods for controlling and operating such devices are disclosed. A negative pressure wound therapy apparatus can include a housing, a negative pressure source, controller, and output device supported by the housing. The negative pressure source can couple via a fluid flow path to a wound dressing and provides negative pressure to the wound dressing. The controller can operate the negative pressure source to provide negative pressure to the wound. The output device can provide identification data to an electronic device, and the identification data can be usable by the electronic device to access a label associated with the negative pressure wound therapy device.

A reusable respirator including a mask adapted for covering and conforming to the face around the nose and a mouth of a user, a strap configured to secure the mask to a face of the user, and a filter component. All components of the respirator are capable of being cleaned, disinfected and sterilized at temperatures in excess of 50° C. An outer surface of the mask is substantially smooth and wettable for easily disinfecting and is shaped with a pair of outer shield portions for housing particulate air filters. The outer shield portions each include a closeable vent through the outer surface that is adapted to provide a user seal check and direct air flow through the outer surface for filtering by the respective particulate air filter, which is adapted to filter at least 95% of airborne particles.